Lung Cancers clinical trials

Explore recruiting lung cancers clinical trials.

Recruiting lung cancers studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung Cancers trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IMMUNOTIME « EVALUATION OF THE EFFECT OF TIME OF ADMINISTRATION ON THE ACTIVITY ON FIRST LINE OF PEMBROLIZUMAB IN ASSOCIATION WITH CARBOPLATIN PEMETREXED IN METASTATIC NON-SQUAMOUS LUNG CANCER. A RANDOMISED MULTICENTER PHASE III TRIAL»

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers

Spain, Netherlands, Germany, France, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)

Belgium, Netherlands, Italy, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)

Spain, Italy, Germany, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non small Cell Lung Cancers, Negative for PD L1, and Positive for KRAS p.G12C (CodeBreaK 202)

Poland, Greece, Belgium, Portugal, Hungary, Netherlands +11 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

First in Human Study of TOS-358 in Adults with Soid Tumors

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Lung Cancers trials by city

Lung Cancers in Toronto Lung Cancers in Vancouver Lung Cancers in Montreal Lung Cancers in Calgary Lung Cancers in Edmonton Lung Cancers in Ottawa Lung Cancers in Winnipeg Lung Cancers in Quebec City Lung Cancers in Hamilton Lung Cancers in Kitchener Lung Cancers in London Lung Cancers in Halifax Lung Cancers in New York Lung Cancers in Los Angeles Lung Cancers in Chicago Lung Cancers in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease